Rosalee Zackula
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rosalee Zackula has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
- Talkad S. Raghuveer
Department of Pediatrics, University of Kansas Medical School-Wichita, Wichita
6 shared publications - Anne Walling
University of Kansas School of Medicine
2 shared publications David A. Grainger
University of Kansas School of Medicine-Wichita, Department of Obstetrics and Gynecology, 1010 North Kansas, Wichita, KS, 67214, USA
2 shared publicationsGretchen Dickson
2 shared publications- Jonathan Wilcher
Kansas City Campus, Department of Emergency Medicine, The University of Kansas Health System, Kansas City, KS, United States
2 shared publications - Lisette T. Jacobson
Department of Population Health, University of Kansas School of Medicine—Wichita, Wichita, KS 67214, USA
2 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by The University of Kansas in Kansas Journal of Medicine
- Vol. 19 (5) , 133-147
Changes in Burnout and Other Types of Emotional Distress Among KUSM Medical Students Between 2019 and 2025
Background. Burnout among medical students is associated with depression, fatigue, suicidal ideation, and impaired academic performance. Authors evaluated changes in burnout and well-being among medical students at the University of Kansas School of Medicine (KUSM) between 2019 and 2025 and explored students’ perspectives on promoting wellness.Methods. A repeated cross-sectional, anonymous online survey was administered to all KUSM medical students in 2025. Measures included burnout, depression, fatigue, quality of life, general health, suicidal ideation, and open-ended wellness questions. Quantitative findings were compared with a similar 2019 survey. Bivariate analyses, multivariable logistic regression, and thematic analysis were performed.Results. Of 808 eligible students, 295 participated (36.5%) and 288 completed the survey (response rate, 35.6%). Overall burnout prevalence remained similar to 2019 (43.4% vs. 48.0%), although depersonalization decreased significantly (16.3% vs. 26.5%; p=0.002). Depression remained common (40.4%), while fatigue worsened significantly (p=0.018). Overall, 7.6% of respondents reported suicidal ideation during the previous 12 months. Burnout was significantly associated with depression, fatigue, and suicidal ideation (all p <0.001). Third-year students had the highest rates of psychological distress and more than twice the odds of screening positive for depression than first-year students (aOR, 2.13; 95% CI, 1.04-4.36). Qualitative analysis identified 10 themes, with students attributing burnout primarily to insufficient time, limited flexibility, excessive workload, and reduced autonomy.Conclusions. Burnout remains highly prevalent among medical students and is closely associated with depression, fatigue, and suicidal ideation. Students emphasized the need for system-level interventions that increase flexibility, protected time, and autonomy to improve learner well-being.
- 16 October 2026
- Published by The University of Kansas in Kansas Journal of Medicine
- Vol. 19 (5) , 133-147
Open AccessChanges in Burnout and Other Types of Emotional Distress Among KUSM Medical Students Between 2019 and 2025
Background. Burnout among medical students is associated with depression, fatigue, suicidal ideation, and impaired academic performance. Authors evaluated changes in burnout and well-being among medical students at the University of Kansas School of Medicine (KUSM) between 2019 and 2025 and explored students’ perspectives on promoting wellness.Methods. A repeated cross-sectional, anonymous online survey was administered to all KUSM medical students in 2025. Measures included burnout, depression, fatigue, quality of life, general health, suicidal ideation, and open-ended wellness questions. Quantitative findings were compared with a similar 2019 survey. Bivariate analyses, multivariable logistic regression, and thematic analysis were performed.Results. Of 808 eligible students, 295 participated (36.5%) and 288 completed the survey (response rate, 35.6%). Overall burnout prevalence remained similar to 2019 (43.4% vs. 48.0%), although depersonalization decreased significantly (16.3% vs. 26.5%; p=0.002). Depression remained common (40.4%), while fatigue worsened significantly (p=0.018). Overall, 7.6% of respondents reported suicidal ideation during the previous 12 months. Burnout was significantly associated with depression, fatigue, and suicidal ideation (all p <0.001). Third-year students had the highest rates of psychological distress and more than twice the odds of screening positive for depression than first-year students (aOR, 2.13; 95% CI, 1.04-4.36). Qualitative analysis identified 10 themes, with students attributing burnout primarily to insufficient time, limited flexibility, excessive workload, and reduced autonomy.Conclusions. Burnout remains highly prevalent among medical students and is closely associated with depression, fatigue, and suicidal ideation. Students emphasized the need for system-level interventions that increase flexibility, protected time, and autonomy to improve learner well-being.
- Open Access
- 23 February 2026
- Published by The University of Kansas in Kansas Journal of Medicine
- Vol. 19 (1) , 20-23
Does Mortality Risk Increase with Active Treatment of Patent Ductus Arteriosus in Preterm Infants? A Critical Appraisal Skills Programme (CASP) Assessment of a Meta-Analysis
Type of Investigation: A meta-analysis of randomized controlled trials (RCT). Question: Do clinical outcomes differ when active treatment is compared to expectant management of hemodynamically significant Patent Ductus Arteriosus (hsPDA) in preterm infants enrolled in randomized controlled trials? METHODS Design. Systematic review with meta-analysis of RCTs. Setting. Ten internationally located neonatal intensive care units. Participants. RCTs that compared active treatment group (ATG) to expectant management group (EMG) for hsPDA in preterm infants. Inclusion Criteria. RCTs that enrolled preterm infants born before 33 weeks' gestation, diagnosed with hsPDA by clinical or echocardiographic criteria, which compared ATG vs. EMG. Exclusion Criteria. Studies that administered treatment for prophylaxis against hsPDA. Randomization. Method of randomization varied by study. Intervention. Infants in ATG received either indomethacin, ibuprofen, acetaminophen, or a combination of medications. Controls. Premature infants in EMG did not receive treatment or received placebo. Consent. Details of ethical review and informed consent were reported in the eligible RCTs. Primary Outcomes. Composite outcome of death at 36 weeks postmenstrual age (PMA) or at discharge, or moderate to severe bronchopulmonary dysplasia (BPD); Composite outcome of death at 36 weeks PMA or moderate to severe BPD; Death at 36 weeks PMA; Death at 36 weeks PMA or at discharge; Moderate to severe BPD. Secondary Outcomes. Death before hospital discharge; death at 28 days; cause of death; intraventricular hemorrhage; periventricular leukomalacia (PVL); retinopathy of prematurity (ROP; stage 3 or treated ROP); pulmonary hemorrhage; cardiovascular support (hypotension, inotropic support, or both); pulmo
- 23 February 2026
- Published by The University of Kansas in Kansas Journal of Medicine
- Vol. 19 (1) , 20-23
Open AccessDoes Mortality Risk Increase with Active Treatment of Patent Ductus Arteriosus in Preterm Infants? A Critical Appraisal Skills Programme (CASP) Assessment of a Meta-Analysis
Type of Investigation: A meta-analysis of randomized controlled trials (RCT). Question: Do clinical outcomes differ when active treatment is compared to expectant management of hemodynamically significant Patent Ductus Arteriosus (hsPDA) in preterm infants enrolled in randomized controlled trials? METHODS Design. Systematic review with meta-analysis of RCTs. Setting. Ten internationally located neonatal intensive care units. Participants. RCTs that compared active treatment group (ATG) to expectant management group (EMG) for hsPDA in preterm infants. Inclusion Criteria. RCTs that enrolled preterm infants born before 33 weeks' gestation, diagnosed with hsPDA by clinical or echocardiographic criteria, which compared ATG vs. EMG. Exclusion Criteria. Studies that administered treatment for prophylaxis against hsPDA. Randomization. Method of randomization varied by study. Intervention. Infants in ATG received either indomethacin, ibuprofen, acetaminophen, or a combination of medications. Controls. Premature infants in EMG did not receive treatment or received placebo. Consent. Details of ethical review and informed consent were reported in the eligible RCTs. Primary Outcomes. Composite outcome of death at 36 weeks postmenstrual age (PMA) or at discharge, or moderate to severe bronchopulmonary dysplasia (BPD); Composite outcome of death at 36 weeks PMA or moderate to severe BPD; Death at 36 weeks PMA; Death at 36 weeks PMA or at discharge; Moderate to severe BPD. Secondary Outcomes. Death before hospital discharge; death at 28 days; cause of death; intraventricular hemorrhage; periventricular leukomalacia (PVL); retinopathy of prematurity (ROP; stage 3 or treated ROP); pulmonary hemorrhage; cardiovascular support (hypotension, inotropic support, or both); pulmo
- 5 November 2025
- Published by Springer Nature in Journal of Perinatology
- Vol. 46 (2) , 321-325
Do systemic steroids impact survival free of cerebral palsy in preterm infants at risk for bronchopulmonary dysplasia?
- 5 November 2025
- Published by Springer Nature in Journal of Perinatology
- Vol. 46 (2) , 321-325
Do systemic steroids impact survival free of cerebral palsy in preterm infants at risk for bronchopulmonary dysplasia?
- 2 September 2024
- Published by Springer Nature in Journal of Perinatology
- Vol. 46 (2) , 144-154
Systemic steroids and bronchopulmonary dysplasia: a systematic review and meta-analysis
Importance It is unclear if systemic steroids decrease the risk of Bronchopulmonary Dysplasia (BPD) while increasing the risk of neurodevelopmental impairment (NDI). Objective Conduct a systematic review of randomized controlled trials of systemic steroids to evaluate the risk of BPD, mortality, and NDI in premature infants ≤30 weeks. Data sources MEDLINE, EBSCOhost, Web of Science, Cochrane Library, Embase, and CINAHL. Study selection Randomized clinical trials of Dexamethasone (DEX) or Hydrocortisone (HC) to prevent BPD in premature infants ≤ 30 weeks. Data extraction and synthesis Data were extracted using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Random-effects meta-analyses and multivariable meta-regression were conducted. Main outcomes and measures Primary outcomes were BPD, mortality, and NDI. Secondary outcomes were hypertension, hyperglycemia, sepsis, intestinal perforation, necrotizing enterocolitis (NEC), and retinopathy of prematurity (ROP). The a priori hypothesis was that steroids would reduce the risk of BPD without increasing NDI. Results There were 6377 preterm infants in the 44 (32 DEX, 13 HC) selected studies. DEX significantly reduced the risk of BPD, RR = 0.66, (95% CI, 0.56–0.78). The most effective DEX regimen was medium cumulative dose (2 to 3 mg/kg), RR = 0.43 (95% CI, 0.29–0.65); day of initiation <8 days: RR = 0.68, (95% CI, 0.59–0.79); and treatment for ≥14 days: RR = 0.67 (95% CI, 0.55–0.80). HC did not significantly decrease the risk of BPD, RR = 0.98, (95% CI, 0.87–1.10). Neither DEX, (RR = 0.92, 95% CI, 0.78–1.09) nor HC (RR = 0.83, 95% CI, 0.68–1.01) decrease the risk of mortality. The risk of CP was not increased by either DEX (RR = 1.09, 95% CI, 0.55–2.17) or HC (RR = 1.18, 95% CI, 0.75–1.87). There were no significant differences between steroids and placebo for MDI/PDI scores. Multivariable meta-regression models showed that DEX significantly reduced the risk of BPD without increased risk of CP. DEX increased the risk of hypertension and hyperglycemia. Studies showed high heterogeneity, differing treatment regimen, missing data and different rates of follow-up. Conclusion and relevance DEX, but not HC, significantly decreased the risk of BPD. Neither steroid showed an increased risk of NDI or mortality.
- 2 September 2024
- Published by Springer Nature in Journal of Perinatology
- Vol. 46 (2) , 144-154
Systemic steroids and bronchopulmonary dysplasia: a systematic review and meta-analysis
Importance It is unclear if systemic steroids decrease the risk of Bronchopulmonary Dysplasia (BPD) while increasing the risk of neurodevelopmental impairment (NDI). Objective Conduct a systematic review of randomized controlled trials of systemic steroids to evaluate the risk of BPD, mortality, and NDI in premature infants ≤30 weeks. Data sources MEDLINE, EBSCOhost, Web of Science, Cochrane Library, Embase, and CINAHL. Study selection Randomized clinical trials of Dexamethasone (DEX) or Hydrocortisone (HC) to prevent BPD in premature infants ≤ 30 weeks. Data extraction and synthesis Data were extracted using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Random-effects meta-analyses and multivariable meta-regression were conducted. Main outcomes and measures Primary outcomes were BPD, mortality, and NDI. Secondary outcomes were hypertension, hyperglycemia, sepsis, intestinal perforation, necrotizing enterocolitis (NEC), and retinopathy of prematurity (ROP). The a priori hypothesis was that steroids would reduce the risk of BPD without increasing NDI. Results There were 6377 preterm infants in the 44 (32 DEX, 13 HC) selected studies. DEX significantly reduced the risk of BPD, RR = 0.66, (95% CI, 0.56–0.78). The most effective DEX regimen was medium cumulative dose (2 to 3 mg/kg), RR = 0.43 (95% CI, 0.29–0.65); day of initiation <8 days: RR = 0.68, (95% CI, 0.59–0.79); and treatment for ≥14 days: RR = 0.67 (95% CI, 0.55–0.80). HC did not significantly decrease the risk of BPD, RR = 0.98, (95% CI, 0.87–1.10). Neither DEX, (RR = 0.92, 95% CI, 0.78–1.09) nor HC (RR = 0.83, 95% CI, 0.68–1.01) decrease the risk of mortality. The risk of CP was not increased by either DEX (RR = 1.09, 95% CI, 0.55–2.17) or HC (RR = 1.18, 95% CI, 0.75–1.87). There were no significant differences between steroids and placebo for MDI/PDI scores. Multivariable meta-regression models showed that DEX significantly reduced the risk of BPD without increased risk of CP. DEX increased the risk of hypertension and hyperglycemia. Studies showed high heterogeneity, differing treatment regimen, missing data and different rates of follow-up. Conclusion and relevance DEX, but not HC, significantly decreased the risk of BPD. Neither steroid showed an increased risk of NDI or mortality.
- 10 May 2024
- Published by Springer Nature in Journal of Perinatology
- Vol. 45 (2) , 282-286
Aflibercept to treat retinopathy of prematurity: need for more research
Until recently, the standard care for retinopathy of prematurity (ROP) was destructive treatment of the peripheral avascular retina, most often using laser therapy. Now, intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents have been included in recommendations for treatment-warranted ROP. The three anti-VEGF agents used to treat ROP are bevacizumab, ranibizumab, and aflibercept and clinical trials using, a variety of treatment strategies, have shown all three are efficacious and easy to administer. Intravitreal Bevacizumab is most used in the US, and ranibizumab has been approved for ROP use in Europe. In 2023, the FDA approved aflibercept for treatment of severe ROP. We summarize the clinical trial results and provide a side-by-side comparisons of the three drugs. Despite FDA approval of the use of aflibercept to treat ROP, there is a need for more research as the body of knowledge regarding this agent to treat ROP is limited.
- 10 May 2024
- Published by Springer Nature in Journal of Perinatology
- Vol. 45 (2) , 282-286
Aflibercept to treat retinopathy of prematurity: need for more research
Until recently, the standard care for retinopathy of prematurity (ROP) was destructive treatment of the peripheral avascular retina, most often using laser therapy. Now, intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents have been included in recommendations for treatment-warranted ROP. The three anti-VEGF agents used to treat ROP are bevacizumab, ranibizumab, and aflibercept and clinical trials using, a variety of treatment strategies, have shown all three are efficacious and easy to administer. Intravitreal Bevacizumab is most used in the US, and ranibizumab has been approved for ROP use in Europe. In 2023, the FDA approved aflibercept for treatment of severe ROP. We summarize the clinical trial results and provide a side-by-side comparisons of the three drugs. Despite FDA approval of the use of aflibercept to treat ROP, there is a need for more research as the body of knowledge regarding this agent to treat ROP is limited.
- Open Access
- 24 August 2023
- Published by The University of Kansas in Kansas Journal of Medicine
- Vol. 16 (2) , 222-227
A Scoping Review to Assess Risk of Fracture Associated with Anxiolytic Medications
Introduction. Recent research has focused on evaluating the impact of pharmalogical sources on fracture risk. The purpose of this study was to review the literature on anxiolytic medications that may be associated with an increased risk of fracture. Methods. A search was conducted in MEDLINE and Embase databases to identify primary clinical studies of patients who sustained a fracture while prescribed anxiolytic medications and were published prior to July 2021. Anxiolytics defined by ATC Class N05B, beta blockers, and zolpidem were included. The search terms consisted of variations of the following: (“Psychotropic Drugs” or MeSH terms) AND (“Fracture” or MeSH terms). Results. Of 3,213 studies, 13 (0.4%) met inclusion criteria and were evaluated. Fractures associated with benzodiazepine were reported in 12 of 13 studies; the highest risk occurred in patients aged 60 years and older, RR=2.29, 95% CI (1.48-4.40). The ATC Class N05B showed an increased fracture risk for those < 55 years of age that differed by sex: for men RR=5.42, 95% CI(4.86-6.05) and for women it was RR=3.33, 95% CI (3.03-3.66). Zolpidem also showed an increase fracture risk, RR=2.29, 95% CI(1.48-3.56), but only during the first 4 weeks of treatment. A relative risk of 0.77, 95% CI(.72-.83) was observed for beta blockers. Conclusions. Fractures are a mainstay of traumatic injuries and are accompanied by economical, physiological, and psychological hardship. Fortunately, with proper assessment and prophylactic measures, fracture risk can be reduced dramatically. Anxiolytic medications have been described widely to increase fracture risk, such as benzodiazepines in 60+ year old patients, and ATC Class N05B Anxiolytics increased fracture risk of RR=5.42, 95% CI (4.86-6.05) in 55+ year old men and in 55+ year old women. Yet, some studies showed that at low doses, nitrazepam lowered fracture risk. Other anxiolytic medications, such as zolpidem and beta blockers, also showed a decrease in fracture risk; however, only one study has been published on each of these medications. Ultimately, this scoping review helped to illuminate the inconsistency of anxiolytic fracture risk assessment while simultaneously illustrating the necessary steps to guide future research.
- 24 August 2023
- Published by The University of Kansas in Kansas Journal of Medicine
- Vol. 16 (2) , 222-227
Open AccessA Scoping Review to Assess Risk of Fracture Associated with Anxiolytic Medications
Introduction. Recent research has focused on evaluating the impact of pharmalogical sources on fracture risk. The purpose of this study was to review the literature on anxiolytic medications that may be associated with an increased risk of fracture. Methods. A search was conducted in MEDLINE and Embase databases to identify primary clinical studies of patients who sustained a fracture while prescribed anxiolytic medications and were published prior to July 2021. Anxiolytics defined by ATC Class N05B, beta blockers, and zolpidem were included. The search terms consisted of variations of the following: (“Psychotropic Drugs” or MeSH terms) AND (“Fracture” or MeSH terms). Results. Of 3,213 studies, 13 (0.4%) met inclusion criteria and were evaluated. Fractures associated with benzodiazepine were reported in 12 of 13 studies; the highest risk occurred in patients aged 60 years and older, RR=2.29, 95% CI (1.48-4.40). The ATC Class N05B showed an increased fracture risk for those < 55 years of age that differed by sex: for men RR=5.42, 95% CI(4.86-6.05) and for women it was RR=3.33, 95% CI (3.03-3.66). Zolpidem also showed an increase fracture risk, RR=2.29, 95% CI(1.48-3.56), but only during the first 4 weeks of treatment. A relative risk of 0.77, 95% CI(.72-.83) was observed for beta blockers. Conclusions. Fractures are a mainstay of traumatic injuries and are accompanied by economical, physiological, and psychological hardship. Fortunately, with proper assessment and prophylactic measures, fracture risk can be reduced dramatically. Anxiolytic medications have been described widely to increase fracture risk, such as benzodiazepines in 60+ year old patients, and ATC Class N05B Anxiolytics increased fracture risk of RR=5.42, 95% CI (4.86-6.05) in 55+ year old men and in 55+ year old women. Yet, some studies showed that at low doses, nitrazepam lowered fracture risk. Other anxiolytic medications, such as zolpidem and beta blockers, also showed a decrease in fracture risk; however, only one study has been published on each of these medications. Ultimately, this scoping review helped to illuminate the inconsistency of anxiolytic fracture risk assessment while simultaneously illustrating the necessary steps to guide future research.
- Open Access
- 28 February 2023
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 25 (1) , e42021
Attitudes and Experiences of Clinicians After Mandated Implementation of Open Notes by the 21st Century Cures Act: Survey Study
Background: On December 13, 2016, the US Congress enacted the 21st Century Cures Act (hereafter the Cures Act), which contained the Final Rule mandate that took effect on April 5, 2021. Since then, health systems have been required to provide patients digital access to their eHealth information “without delay” and without charge. Objective: This study aimed to assess clinicians’ initial experiences with, and attitudes toward, sharing visit notes with patients after being mandated to do so by the Cures Act and to determine clinician preferences regarding instant record release. Methods: This cross-sectional survey study was conducted between June 10, 2021, and August 15, 2021, at the University of Kansas Health System, a large academic medical center in Kansas City, Kansas, United States. Participants included clinicians currently employed by the health system, including resident and attending physicians, physician assistants, nurse practitioners, and critical care and emergency medicine registered nurses. Results: A total of 1574 attending physicians, physician assistants, and nurse practitioners, as well as 506 critical care and emergency medicine nurses, were sent invitations; 538 (34.18%) and 72 (14.2%), respectively, responded. Of 609 resident physicians, 4 (response rate not applicable because it was unknown how many residents viewed the website while the link was available) responded. The majority of respondents were attending physicians (402/614, 65.5%) and within the department of internal medicine (160/614, 26.1%). Most agreed that sharing visit notes was a good idea (355/613, 57.9%) and that it is important to speak with the patients before they accessed their records (431/613, 70.3%). Those who agreed that sharing visit notes is a good idea tended to view the practice as a useful tool for engaging patients (“Agree”: 139/355, 39.2%; “Somewhat agree”: 161/355, 45.4%; P<.001) and experience no change in the clinical value of their notes for other clinicians (326/355, 91.8%; P<.001). Those who disagreed (or were neutral) tended not to encourage patients to read their notes (235/258, 91.1%; P<.001) and were more likely to experience a change in their charting practice (168/257, 65.4%; P<.001) and increased time charting (99/258, 38.4%; P<.001). Conclusions: The findings of this study may be generalizable to institutions similar to the University of Kansas Health System, and the clinician testimonies gathered in this study may provide valuable insight into the initial opinions and experiences of clinicians at these institutions. In addition, these clinician experiences collected early in the transition period may be used to guide future health policy implementation and to understand how best to prepare clinicians for these changes in practice.
- 28 February 2023
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 25 (1) , e42021
Open AccessAttitudes and Experiences of Clinicians After Mandated Implementation of Open Notes by the 21st Century Cures Act: Survey Study
Background: On December 13, 2016, the US Congress enacted the 21st Century Cures Act (hereafter the Cures Act), which contained the Final Rule mandate that took effect on April 5, 2021. Since then, health systems have been required to provide patients digital access to their eHealth information “without delay” and without charge. Objective: This study aimed to assess clinicians’ initial experiences with, and attitudes toward, sharing visit notes with patients after being mandated to do so by the Cures Act and to determine clinician preferences regarding instant record release. Methods: This cross-sectional survey study was conducted between June 10, 2021, and August 15, 2021, at the University of Kansas Health System, a large academic medical center in Kansas City, Kansas, United States. Participants included clinicians currently employed by the health system, including resident and attending physicians, physician assistants, nurse practitioners, and critical care and emergency medicine registered nurses. Results: A total of 1574 attending physicians, physician assistants, and nurse practitioners, as well as 506 critical care and emergency medicine nurses, were sent invitations; 538 (34.18%) and 72 (14.2%), respectively, responded. Of 609 resident physicians, 4 (response rate not applicable because it was unknown how many residents viewed the website while the link was available) responded. The majority of respondents were attending physicians (402/614, 65.5%) and within the department of internal medicine (160/614, 26.1%). Most agreed that sharing visit notes was a good idea (355/613, 57.9%) and that it is important to speak with the patients before they accessed their records (431/613, 70.3%). Those who agreed that sharing visit notes is a good idea tended to view the practice as a useful tool for engaging patients (“Agree”: 139/355, 39.2%; “Somewhat agree”: 161/355, 45.4%; P<.001) and experience no change in the clinical value of their notes for other clinicians (326/355, 91.8%; P<.001). Those who disagreed (or were neutral) tended not to encourage patients to read their notes (235/258, 91.1%; P<.001) and were more likely to experience a change in their charting practice (168/257, 65.4%; P<.001) and increased time charting (99/258, 38.4%; P<.001). Conclusions: The findings of this study may be generalizable to institutions similar to the University of Kansas Health System, and the clinician testimonies gathered in this study may provide valuable insight into the initial opinions and experiences of clinicians at these institutions. In addition, these clinician experiences collected early in the transition period may be used to guide future health policy implementation and to understand how best to prepare clinicians for these changes in practice.
- Open Access
- 18 August 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Attitudes and Experiences of Clinicians After Mandated Implementation of Open Notes by the 21st Century Cures Act: Survey Study (Preprint)
BACKGROUND On December 13, 2016, the US Congress enacted the 21st Century Cures Act (hereafter the Cures Act), which contained the Final Rule mandate that took effect on April 5, 2021. Since then, health systems have been required to provide patients digital access to their eHealth information “without delay” and without charge. OBJECTIVE This study aimed to assess clinicians’ initial experiences with, and attitudes toward, sharing visit notes with patients after being mandated to do so by the Cures Act and to determine clinician preferences regarding instant record release. METHODS This cross-sectional survey study was conducted between June 10, 2021, and August 15, 2021, at the University of Kansas Health System, a large academic medical center in Kansas City, Kansas, United States. Participants included clinicians currently employed by the health system, including resident and attending physicians, physician assistants, nurse practitioners, and critical care and emergency medicine registered nurses. RESULTS A total of 1574 attending physicians, physician assistants, and nurse practitioners, as well as 506 critical care and emergency medicine nurses, were sent invitations; 538 (34.18%) and 72 (14.2%), respectively, responded. Of 609 resident physicians, 4 (response rate not applicable because it was unknown how many residents viewed the website while the link was available) responded. The majority of respondents were attending physicians (402/614, 65.5%) and within the department of internal medicine (160/614, 26.1%). Most agreed that sharing visit notes was a good idea (355/613, 57.9%) and that it is important to speak with the patients before they accessed their records (431/613, 70.3%). Those who agreed that sharing visit notes is a good idea tended to view the practice as a useful tool for engaging patients (“Agree”: 139/355, 39.2%; “Somewhat agree”: 161/355, 45.4%; P<.001) and experience no change in the clinical value of their notes for other clinicians (326/355, 91.8%; P<.001). Those who disagreed (or were neutral) tended not to encourage patients to read their notes (235/258, 91.1%; P<.001) and were more likely to experience a change in their charting practice (168/257, 65.4%; P<.001) and increased time charting (99/258, 38.4%; P<.001). CONCLUSIONS The findings of this study may be generalizable to institutions similar to the University of Kansas Health System, and the clinician testimonies gathered in this study may provide valuable insight into the initial opinions and experiences of clinicians at these institutions. In addition, these clinician experiences collected early in the transition period may be used to guide future health policy implementation and to understand how best to prepare clinicians for these changes in practice.
- 18 August 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAttitudes and Experiences of Clinicians After Mandated Implementation of Open Notes by the 21st Century Cures Act: Survey Study (Preprint)
BACKGROUND On December 13, 2016, the US Congress enacted the 21st Century Cures Act (hereafter the Cures Act), which contained the Final Rule mandate that took effect on April 5, 2021. Since then, health systems have been required to provide patients digital access to their eHealth information “without delay” and without charge. OBJECTIVE This study aimed to assess clinicians’ initial experiences with, and attitudes toward, sharing visit notes with patients after being mandated to do so by the Cures Act and to determine clinician preferences regarding instant record release. METHODS This cross-sectional survey study was conducted between June 10, 2021, and August 15, 2021, at the University of Kansas Health System, a large academic medical center in Kansas City, Kansas, United States. Participants included clinicians currently employed by the health system, including resident and attending physicians, physician assistants, nurse practitioners, and critical care and emergency medicine registered nurses. RESULTS A total of 1574 attending physicians, physician assistants, and nurse practitioners, as well as 506 critical care and emergency medicine nurses, were sent invitations; 538 (34.18%) and 72 (14.2%), respectively, responded. Of 609 resident physicians, 4 (response rate not applicable because it was unknown how many residents viewed the website while the link was available) responded. The majority of respondents were attending physicians (402/614, 65.5%) and within the department of internal medicine (160/614, 26.1%). Most agreed that sharing visit notes was a good idea (355/613, 57.9%) and that it is important to speak with the patients before they accessed their records (431/613, 70.3%). Those who agreed that sharing visit notes is a good idea tended to view the practice as a useful tool for engaging patients (“Agree”: 139/355, 39.2%; “Somewhat agree”: 161/355, 45.4%; P<.001) and experience no change in the clinical value of their notes for other clinicians (326/355, 91.8%; P<.001). Those who disagreed (or were neutral) tended not to encourage patients to read their notes (235/258, 91.1%; P<.001) and were more likely to experience a change in their charting practice (168/257, 65.4%; P<.001) and increased time charting (99/258, 38.4%; P<.001). CONCLUSIONS The findings of this study may be generalizable to institutions similar to the University of Kansas Health System, and the clinician testimonies gathered in this study may provide valuable insight into the initial opinions and experiences of clinicians at these institutions. In addition, these clinician experiences collected early in the transition period may be used to guide future health policy implementation and to understand how best to prepare clinicians for these changes in practice.
- Open Access
- 17 May 2022
- Published by The University of Kansas in Kansas Journal of Medicine
- Vol. 15 (2) , 170-174
Causes of Anemia in Patients Seen in a Rural Community Hematology Clinic
Introduction. Anemia is a common medical disorder seen in consultation by hematologists. This study was performed to determine the incidence of the etiologies causing anemia in patients referred to the hematologists at Tammy Walker Cancer Center (TWCC) in the rural Kansas community of Salina. An additional goal of the study was to compare the frequencies of different etiologies for anemia in this cohort of patients with those previously reported by four academic medical centers. Methods. A retrospective review of the medical records of 152 patients seen at TWCC between August 2015 and May 2019 was performed. The patient’s history and physical exam, complete blood count and various additional hematologic studies ordered at the discretion of the TWCC hematologist were used to determine the etiology of each patient’s anemia. Results. The most common causes of anemia found in the chart review were iron deficiency (48.7%), hematologic malignancy (14.5%), chronic inflammation (13.8%), renal insufficiency (11.2%), and unexplained anemia (9.9%). While the incidences of anemia due to hematologic malignancy, chronic inflammation, and renal insufficiency were similar to that reported previously by four academic medical centers, significantly more iron deficiency and less unexplained anemia were found in the patients referred to TWCC. Conclusions. The causes of anemia in patients seen at TWCC were similar to those reported by academic medical centers; however, the incidences were different. The differences in findings may reflect dissimilarities in the demographics of referral populations, the duration and extent of the evaluation at TWCC, or referral patterns.
- 17 May 2022
- Published by The University of Kansas in Kansas Journal of Medicine
- Vol. 15 (2) , 170-174
Open AccessCauses of Anemia in Patients Seen in a Rural Community Hematology Clinic
Introduction. Anemia is a common medical disorder seen in consultation by hematologists. This study was performed to determine the incidence of the etiologies causing anemia in patients referred to the hematologists at Tammy Walker Cancer Center (TWCC) in the rural Kansas community of Salina. An additional goal of the study was to compare the frequencies of different etiologies for anemia in this cohort of patients with those previously reported by four academic medical centers. Methods. A retrospective review of the medical records of 152 patients seen at TWCC between August 2015 and May 2019 was performed. The patient’s history and physical exam, complete blood count and various additional hematologic studies ordered at the discretion of the TWCC hematologist were used to determine the etiology of each patient’s anemia. Results. The most common causes of anemia found in the chart review were iron deficiency (48.7%), hematologic malignancy (14.5%), chronic inflammation (13.8%), renal insufficiency (11.2%), and unexplained anemia (9.9%). While the incidences of anemia due to hematologic malignancy, chronic inflammation, and renal insufficiency were similar to that reported previously by four academic medical centers, significantly more iron deficiency and less unexplained anemia were found in the patients referred to TWCC. Conclusions. The causes of anemia in patients seen at TWCC were similar to those reported by academic medical centers; however, the incidences were different. The differences in findings may reflect dissimilarities in the demographics of referral populations, the duration and extent of the evaluation at TWCC, or referral patterns.
- Open Access
- 15 March 2022
- Published by The University of Kansas in Kansas Journal of Medicine
- Vol. 15 (1) , 97-100
Improving Electronic Patient Handoff in an Orthopedic Residency using the Listrunner© Application.
Introduction. Miscommunication during shift change and other handoff events is a common source of malpractice claims and patient-care errors. An efficient patient handoff system is imperative to prevent miscommunication. Owning to limitations with our current handoff system and to an ever-increasing reliance on electronic health information, our residency program sought to modernize our handoff method. Methods. To improve handoff communication, we adopted the HIPAA-compliant application Listrunner©. Members of the orthopaedic trauma team were oriented to the new application. Change-of-shift patient handoff was then transitioned from the current email system to Listrunner©. After three months of using the new application, a web-based questionnaire was administered to all members of the care team to assess their experiences, including perceived benefits and limitations of the Listrunner© application. Results. Seventeen orthopaedic resident physicians and three orthopaedic trauma attending physicians completed the survey. While almost half of the respondents were satisfied using email as a checkout tool, more than half of study participants indicated that it lacked security and several users believed there was a need for improvement. Most indicated that Listrunner© was easy to use, improved clinical efficiency, and improved patient care and safety. Seventeen of 20 respondents reported that they would like to continue using Listrunner© as a checkout tool. Conclusions. The Listrunner© application was quickly adopted by our orthopaedic trauma team, whose members opined that the application increased the efficiency and accuracy of handoff when compared to the previous secure email system.
- 15 March 2022
- Published by The University of Kansas in Kansas Journal of Medicine
- Vol. 15 (1) , 97-100
Open AccessImproving Electronic Patient Handoff in an Orthopedic Residency using the Listrunner© Application.
Introduction. Miscommunication during shift change and other handoff events is a common source of malpractice claims and patient-care errors. An efficient patient handoff system is imperative to prevent miscommunication. Owning to limitations with our current handoff system and to an ever-increasing reliance on electronic health information, our residency program sought to modernize our handoff method. Methods. To improve handoff communication, we adopted the HIPAA-compliant application Listrunner©. Members of the orthopaedic trauma team were oriented to the new application. Change-of-shift patient handoff was then transitioned from the current email system to Listrunner©. After three months of using the new application, a web-based questionnaire was administered to all members of the care team to assess their experiences, including perceived benefits and limitations of the Listrunner© application. Results. Seventeen orthopaedic resident physicians and three orthopaedic trauma attending physicians completed the survey. While almost half of the respondents were satisfied using email as a checkout tool, more than half of study participants indicated that it lacked security and several users believed there was a need for improvement. Most indicated that Listrunner© was easy to use, improved clinical efficiency, and improved patient care and safety. Seventeen of 20 respondents reported that they would like to continue using Listrunner© as a checkout tool. Conclusions. The Listrunner© application was quickly adopted by our orthopaedic trauma team, whose members opined that the application increased the efficiency and accuracy of handoff when compared to the previous secure email system.